CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $628 | -23.6% | 487 | +1.9% | 0.00% | – |
| Q2 2023 | $822 | +19.1% | 478 | +4.6% | 0.00% | – |
| Q1 2023 | $690 | -4.2% | 457 | +1.6% | 0.00% | – |
| Q4 2022 | $720 | -28.0% | 450 | +2.7% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 438 | +7.6% | 0.00% | – |
| Q2 2022 | $1,000 | -99.6% | 407 | -99.5% | 0.00% | – |
| Q1 2022 | $228,000 | -49.6% | 85,231 | -18.5% | 0.00% | – |
| Q4 2021 | $452,000 | -1.7% | 104,624 | +15.5% | 0.00% | – |
| Q3 2021 | $460,000 | +37.3% | 90,569 | +71.0% | 0.00% | – |
| Q2 2021 | $335,000 | -70.1% | 52,978 | -63.4% | 0.00% | – |
| Q1 2021 | $1,119,000 | +71.1% | 144,755 | +45.0% | 0.00% | – |
| Q4 2020 | $654,000 | -8.4% | 99,815 | -7.0% | 0.00% | – |
| Q3 2020 | $714,000 | -14.8% | 107,311 | +6.7% | 0.00% | – |
| Q2 2020 | $838,000 | +306.8% | 100,609 | +274.2% | 0.00% | – |
| Q1 2020 | $206,000 | +1.0% | 26,883 | +9.3% | 0.00% | – |
| Q4 2019 | $204,000 | +12.7% | 24,586 | +0.1% | 0.00% | – |
| Q3 2019 | $181,000 | -30.4% | 24,564 | +6.1% | 0.00% | – |
| Q2 2019 | $260,000 | -69.8% | 23,156 | -71.1% | 0.00% | – |
| Q1 2019 | $861,000 | -47.3% | 80,036 | -26.0% | 0.00% | -100.0% |
| Q4 2018 | $1,634,000 | -7.0% | 108,225 | +13.9% | 0.00% | – |
| Q3 2018 | $1,757,000 | -15.4% | 94,985 | +4.4% | 0.00% | -100.0% |
| Q2 2018 | $2,078,000 | +22.6% | 90,965 | +52.6% | 0.00% | 0.0% |
| Q1 2018 | $1,695,000 | -43.4% | 59,601 | -58.0% | 0.00% | 0.0% |
| Q4 2017 | $2,997,000 | +171.5% | 141,954 | +133.7% | 0.00% | – |
| Q3 2017 | $1,104,000 | +72.8% | 60,739 | +47.3% | 0.00% | – |
| Q2 2017 | $639,000 | +65.1% | 41,233 | +83.9% | 0.00% | – |
| Q1 2017 | $387,000 | +140.4% | 22,424 | +52.8% | 0.00% | – |
| Q4 2016 | $161,000 | +32.0% | 14,677 | +88.0% | 0.00% | – |
| Q3 2016 | $122,000 | +430.4% | 7,808 | +253.6% | 0.00% | – |
| Q2 2016 | $23,000 | -25.8% | 2,208 | -6.6% | 0.00% | – |
| Q1 2016 | $31,000 | -34.0% | 2,363 | +5.7% | 0.00% | – |
| Q4 2015 | $47,000 | – | 2,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |